S. Dawn Smith - 09 Jul 2025 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Jul 2025, 16:01:06 UTC
Prior SEC filing
19 May 2025
Next SEC filing
19 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Benjamin Landry, as Attorney-in-Fact

Key filing fact

S. Dawn Smith filed Form 4 for Health Catalyst, Inc. (HCAT) on 11 Jul 2025.

Key facts

  • This page summarizes S. Dawn Smith's Form 4 filing for Health Catalyst, Inc. (HCAT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Jul 2025, 16:01.

Change

  • Previous filing in this sequence was filed on 19 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001473973 Primary reporting owner

Smith S. Dawn

Relationship
Director
Address
C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Signature
/s/Benjamin Landry, as Attorney-in-Fact
Signature date
10 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCAT transaction

Common Stock

Award

Transaction value
$0
Shares
+36,231
Change %
+55%
Price
$0.000000
Shares after
101,692
Date
09 Jul 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .